Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

AGIO Message Board | Agios Pharmaceuticals Inc.

home / stock / agio / agio message board

AGIO AGIO Quote AGIO Short AGIO News AGIO Articles AGIO Message Board
New Post

Message Board | Agios Pharmaceuticals Inc. (NASDAQ:AGIO)

Subject By Source When
whytestocks: $AGIO News Article - Agios to Webcast Conference Call of First Quarter 2023 Financial R whytestocks investorshangout 04/13/2023 3:00:57 PM
whytestocks: $AGIO News Article - Agios Appoints Rahul Ballal and Cynthia Smith to Board of Director whytestocks investorshangout 08/15/2022 3:11:23 PM
whytestocks: $AGIO News Article - Agios Reports Business Highlights and Second Quarter 2022 Financia whytestocks investorshangout 08/04/2022 3:00:57 PM
whytestocks: $AGIO News Article - Agios to Webcast Conference Call of Second Quarter 2022 Financial whytestocks investorshangout 07/14/2022 2:40:52 PM
whytestocks: $AGIO News Article - Agios Appoints Brian Goff as Chief Executive Officer whytestocks investorshangout 07/12/2022 8:50:55 PM
whytestocks: $AGIO News Article - Agios to Present at the RBC Capital Markets Global Healthcare Conf whytestocks investorshangout 05/10/2022 6:25:56 PM
AviseAnalytics: 5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS $AGIO $CYTK $ADGI $PHAT $ICPT Clini AviseAnalytics investorshangout 02/08/2022 1:55:27 PM
whytestocks: $AGIO News Article - Agios Presents Mitapivat Data Highlighting Long-term Safety Profil whytestocks investorshangout 12/13/2021 7:50:49 PM
whytestocks: $AGIO News Article - Agios Announces Data from Investigator-led Studies of Mitapivat in whytestocks investorshangout 12/13/2021 7:20:48 PM
znewcar1: AGIO 28% v5,7M c42.62 f69,2M PreMH48.73 S40 been in a 30-55 channel ATM this year. znewcar1 investorshangout 12/21/2020 9:41:37 PM
Do you have any estimates? TonyJoe1957 investorshub 12/21/2020 3:11:06 PM
Lots of posts. TonyJoe1957 investorshub 12/21/2020 3:06:56 PM
whytestocks: $AGIO News Article - Agios to Webcast Conference Call of Third Quarter 2020 Financial R whytestocks investorshangout 10/22/2020 4:00:56 PM
whytestocks: $AGIO News Article - Agios Announces Withdrawal of European Marketing Authorization App whytestocks investorshangout 10/16/2020 8:30:47 PM
News: $AGIO Agios Pharmaceuticals Raised $294 Million to whytestocks investorshub 11/27/2019 8:04:11 PM
whytestocks: $AGIO News Article - Agios Pharmaceuticals Raised $294 Million to Fight Cancer and Rare whytestocks investorshangout 11/27/2019 4:50:43 PM
News: $AGIO Agios Presents Data from Single Agent whytestocks investorshub 10/27/2019 5:00:23 PM
whytestocks: $AGIO News Article - Agios Presents Updated Data from Phase 1 Studies of TIBSOVO (ivosi whytestocks investorshangout 06/03/2019 5:55:43 PM
$AGIO Bullish after-hours 15% move on positive 8-K filing TFMG investorshub 05/23/2019 12:05:01 AM
AGIOS UP $BIG AFTER HOURS Hyah investorshub 05/16/2019 10:00:51 AM
Next
Stock Information
Get AGIO Alerts

News, Short Squeeze, Breakout and More Instantly...

Agios Pharmaceuticals Inc. Company Name:

AGIO Stock Symbol:

NASDAQ Market:

Agios Pharmaceuticals Inc. Website:

Agios Pharmaceuticals Inc. Logo

Ad

Investor Relations
RECENT AGIO NEWS
  • AGIO - Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

    – FDA Accepted Agios’ Supplemental New Drug Application for PYRUKYND ® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia; PDUFA Goal Date is September 7, 2025 – – Topline Results f...

  • AGIO - FDA Accepts Agios' Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia

    CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) accepted the company’...

  • AGIO - Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

    CAMBRIDGE, Mass., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the 43 rd Annual J.P. Morgan Healthcare...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications
Trending Stock Alerts

Get AGIO Alerts

Get AGIO Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1